reference/24386371

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/24386371

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	363
issn	1365-2036 0269-2813
issueIdentifier	3
pageRange	356-363
publicationName	Alimentary Pharmacology & Therapeutics
startingPage	356
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_2cb2e220a04bd801d96586a09412b6d3 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_f19ca0fa36e7c77712c0f981f92928f1 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_3a16fd606a29978fa92290e51686ae58 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_f74cfc1e054738d9371f02269ed798be http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_7ef8e52f1af38b16c7ee9606732c5b71
bibliographicCitation	Wilson A, Peel C, Wang Q, Pananos AD, Kim RB. HLADQA1*05 genotype predicts anti-drug antibody formation and loss of response during infliximab therapy for inflammatory bowel disease. Aliment Pharmacol Ther. 2020 Feb;51(3):356–63. doi: 10.1111/apt.15563. PMID: 31650614.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_54f02c603b8d398036743420a34e8ee5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-6568-1714 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ec2a066d253923715365b8b376576f58 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_46a8e10325cde28bc50befc697e3a8a4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-8148-1632
date	2019-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/31650614 https://doi.org/10.1111/apt.15563
isPartOf	https://portal.issn.org/resource/ISSN/0269-2813 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1160 https://portal.issn.org/resource/ISSN/1365-2036
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	HLADQA1*05 genotype predicts anti‐drug antibody formation and loss of response during infliximab therapy for inflammatory bowel disease
discusses	http://id.nlm.nih.gov/mesh/M0188581 http://id.nlm.nih.gov/mesh/M0282056 http://id.nlm.nih.gov/mesh/M0551795 http://id.nlm.nih.gov/mesh/M0001352
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000917Q000235 http://id.nlm.nih.gov/mesh/D015212Q000188 http://id.nlm.nih.gov/mesh/D015212Q000235 http://id.nlm.nih.gov/mesh/D000069285Q000627 http://id.nlm.nih.gov/mesh/D000069285Q000276 http://id.nlm.nih.gov/mesh/D004351Q000235 http://id.nlm.nih.gov/mesh/D059848Q000235 http://id.nlm.nih.gov/mesh/D004351Q000276
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D000906Q000378 http://id.nlm.nih.gov/mesh/D000071185 http://id.nlm.nih.gov/mesh/D012189 http://id.nlm.nih.gov/mesh/D064420Q000235 http://id.nlm.nih.gov/mesh/D056726 http://id.nlm.nih.gov/mesh/D015212Q000276 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D015331 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D011379 http://id.nlm.nih.gov/mesh/D064420Q000276 http://id.nlm.nih.gov/mesh/D000917Q000187 http://id.nlm.nih.gov/mesh/D015212Q000175 http://id.nlm.nih.gov/mesh/D005838
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7365 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9679

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3117

Total number of triples: 62.